LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
  • Should you invest £1,000 in AstraZeneca right now?

    When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

    Mark and his analyst team just revealed what they believe are the 6 best stocks for investors to buy right now... and AstraZeneca wasn’t on the list. Right now, they think there are 6 stocks that are better buys!

    See the 6 stocks

  • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    Down 13% from its year high at £116.50 now, AstraZeneca’s share price looks cheap to me anywhere under £219.81

    AstraZeneca’s share price has dropped recently on concerns relating to its Chinese operation, but this may have left the shares…

    Read more »

    The words "what's your plan for retirement" written on chalkboard on pavement somewhere in London
    Dividend Shares

    2 retirement shares that long-term investors should consider for steady income

    Ken Hall takes a look at two big-name retirement shares in the FTSE 100 with market-leading positions and track records…

    Read more »

    Investing Articles

    Here’s why AstraZeneca stock jumped nearly 6% in the FTSE 100 today

    FTSE 100 heavyweight AstraZeneca helped propel the blue-chip index to a record high today. Here's what investors were cheering.

    Read more »

    Investing Articles

    The AstraZeneca share price jumps 5% on today’s strong results – but is it too expensive?

    Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's biggest company…

    Read more »

    Pink 3D image of the numbers '2025' growing in size
    Investing Articles

    I asked ChatGPT to build the perfect Stocks and Shares ISA – and here it is!

    Harvey Jones called on artificial intelligence to help him decide where to invest this year's Stocks and Shares ISA allowance.…

    Read more »

    artificial intelligence investing algorithms
    Growth Shares

    2 FTSE stocks that could do well with the DeepSeek AI breakthrough

    Jon Smith talks through the implications of the latest AI news and flags up some FTSE shares that could benefit…

    Read more »

    Young Caucasian girl showing and pointing up with fingers number three against yellow background
    Investing Articles

    3 key reasons why AstraZeneca’s share price looks a steal to me right now

    AstraZeneca’s share price has fallen a long way from its record-breaking level last year, which indicates that I may be…

    Read more »

    Number three written on white chat bubble on blue background
    Investing Articles

    These are my top 3 defensive shares to buy in 2025!

    Mark Hartley considers three shares he feels could provide stability if markets are volatile -- and if he wants to…

    Read more »

    Investing Articles

    FTSE shares in 2025: an opportunity to get rich?

    The FTSE hasn’t universally satisfied investors in recent years, but there are certainly enticing opportunities on the index in 2025.

    Read more »

    Investing Articles

    I asked ChatGPT for the best UK stocks for me to buy for 2025. Here are 5 names it gave me

    Edward Sheldon turned to artificial intelligence in his quest to find the best UK stocks for him to buy for…

    Read more »

    Investing Articles

    If the market shut down for 10 years, I’d be happy to hold these 2 FTSE 100 shares

    Our writer reveals a pair of FTSE 100 shares that he reckons are well set up to deliver strong returns…

    Read more »

    Investing Articles

    Analysts are saying the AstraZeneca share price looks cheap despite China turmoil

    The AstraZeneca share price could be considerably undervalued according to analysts. Dr James Fox takes a closer look at the…

    Read more »